Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03721822 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Imaging Sex Differences in Smoking-Induced Pulmonary Inflammation

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Oct 23, 2026 → Oct 23, 2027
See other at-risk trials from University of Pennsylvania

Record History

  1. Primary completion pushed from Oct 23, 2026 to Oct 23, 2027 Primary endpoints: details revised at 1 of 1 entry · Completion pushed from Oct 23, 2026 to Oct 23, 2028 · Eligibility criteria expanded, about 12 words · 2 more Show 5 more changesShow less
    • Primary endpoints: details revised at 1 of 1 entry
    • Completion pushed from Oct 23, 2026 to Oct 23, 2028
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: details revised at 2 of 2 entries
    • Study description revised
  2. Eligibility criteria shortened, about 29 words Study arms: 5 to 6v18 Show 1 more changeShow less
    • Study arms: 5 to 6

    See this version in full on ClinicalTrials.gov ↗

  3. Primary and study completion dates: Oct 23, 2024 to Oct 23, 2026v17
  4. 2 versions Re-verified since Jan 24, 2024, no change to tracked fieldsv15-v16
  5. Primary and study completion dates: Oct 23, 2023 to Oct 23, 2024 Eligibility criteria shortened, about 3 wordsv14 Show 1 more changeShow less
    • Eligibility criteria shortened, about 3 words

    See this version in full on ClinicalTrials.gov ↗

Show 12 earlier versionsHide 12 earlier versions
  1. Primary completion date: Oct 23, 2022 to Oct 23, 2023v13
  2. Eligibility criteria shortened, about 38 words Study description expanded, about 250 words · Site contact updatedv12 Show 2 more changesShow less
    • Study description expanded, about 250 words
    • Site contact updated

    See this version in full on ClinicalTrials.gov ↗

  3. Study title revisedv11 See this version in full on ClinicalTrials.gov ↗
  4. Enrollment target: 60 to 100 Eligibility criteria expanded, about 89 words · Study arms: 3 to 5v10 Show 2 more changesShow less
    • Eligibility criteria expanded, about 89 words
    • Study arms: 3 to 5

    See this version in full on ClinicalTrials.gov ↗

  5. Primary completion date: Oct 23, 2020 to Oct 23, 2022 Completion date: Oct 23, 2021 to Oct 23, 2023v9 Show 1 more changeShow less
    • Completion date: Oct 23, 2021 to Oct 23, 2023
  6. Re-verified, no change to tracked fieldsv8
  7. Trial status: Active, Not Recruiting to Recruiting Site details revisedv7 Show 1 more changeShow less
    • Site details revised
  8. Re-verified, no change to tracked fieldsv6
  9. Trial status: Recruiting to Active, Not Recruiting Site details revisedv5 Show 1 more changeShow less
    • Site details revised
  10. Eligibility criteria shortened, about 13 wordsv4 See this version in full on ClinicalTrials.gov ↗
  11. Trial status: Active, Not Recruiting to Recruiting Site details revisedv3 Show 1 more changeShow less
    • Site details revised
  12. Primary endpoint revised Secondary endpoints: details revised at 1 of 2 entriesv2 Show 1 more changeShow less
    • Secondary endpoints: details revised at 1 of 2 entries

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research is to measure the extent of lung inflammation between different groups of participants using a radioactive tracer called \[18F\]NOS. A radioactive tracer is a type of imaging drug that is labeled with a radioactive tag and injected into the body.
Trial Details
NCT Number NCT03721822
Lead Sponsor University of Pennsylvania
Conditions Smoking, Cigarette, Smoking E-cigarette, Healthy Volunteer
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov